Site of action of β-ligands at the human β1-adrenoceptor

Journal of Pharmacology and Experimental Therapeutics

Volumn 313, Issue 3, 2005, Pages 1163-1171

  Baker, Julian G ^a,b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; ADRENALIN; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR; BETAXOLOL; BISOPROLOL; BUPRANOLOL; CARVEDILOL; CATECHOLAMINE; CIMATEROL; FORMOTEROL; ISOPRENALINE; LIGAND; METOPROLOL; NADOLOL; NORADRENALIN; PROPRANOLOL; SOTALOL; TERBUTALINE; TIMOLOL; XAMOTEROL;

ANIMAL CELL; ARTICLE; CELL CULTURE; CHO CELL; CULTURE MEDIUM; CYCLIC AMP RESPONSIVE ELEMENT; DRUG BINDING SITE; DRUG EFFICACY; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PHOSPHORYLATION; REPORTER GENE;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CHO CELLS; CRICETINAE; CYCLIC AMP; HUMANS; ISOENZYMES; LUCIFERASES; PROPANOLAMINES; RECEPTORS, ADRENERGIC, BETA-1; RESPONSE ELEMENTS;

EID: 19444384721     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.082875     Document Type: Article

References (30)

1. Arch JR (2004) Do low-affinity states of beta-adrenoceptors have roles in physiology and medicine? Br J Pharmacol 143:517-518.
2. Arunlakshana O and Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48-58.
3. 2-adrenoceptor. Br J Pharmacol 137:400-408.
4. Baker JG, Hall IP, and Hill SJ (2003a) Influence of agonist efficacy and receptor phosphorylation on antagonist affinity measurements: differences between second messenger and reporter gene responses. Mol Pharmacol 64:679-688.
5. Baker JG, Hall IP, and Hill SJ (2003b) Agonist actions of "β-blockers" provide evidence for two agonist activation sites or conformations of the human β1-adrenoceptor. Mol Pharmacol 63:1312-1321.
6. Black JW, Duncan WA, Durant CJ, Ganellin CR, and Parsons ME (1972) Definition and antagonism of histamine H2-receptors. Nature (Lond) 236:385-390.
7. Black JW, Duncan WA, and Shanks RG (1965) Comparison of some properties of pronethalol and propranolol. Br J Pharmacol 25:577-591.
8. Cohen ML, Bloomquist W, Ito M, and Lowell BB (2000) Beta3 receptors mediate relaxation in stomach fundus whereas a fourth beta receptor mediates tachycardia in atria from transgenic beta3 receptor knockout mice. Receptor Channels 7:17-23.
9. Donaldson J, Brown AM, and Hill SJ (1988) Influence of rolipram on the cyclic-3′,5′-adenosine monophosphate response to histamine and adenosine in slices of guinea-pig cerebral cortex. Biochem Pharmacol 37:715-723.
10. Granneman JG (2001) The putative beta4-adrenergic receptor is a novel state of the beta1-adrenergic receptor. Am J Physiol Endocrinol Metab 280:E199-E202.
11. 2- adrenoceptors. Br J Pharmacol 131: 124-130.
12. 2-adrenoceptor. Br J Pharmacol 123:701-711.
13. Joseph SS, Lynham JA, Colledge WH, and Kaumann AJ (2004) Binding of (-)-[3H]-CGP12177 at two sites in recombinant human beta 1-adrenoceptors and interaction with beta-blockers. Naunyn-Schmiedeberg's Arch Pharmacol 369:525-532.
14. Kaumann AJ, Engelhardt S, Hein L, Molenaar P, and Lohse M (2001) Abolition of (-)-CGP 12177-evoked cardiostimulation in double beta1/beta2-adrenoceptor knockout mice. Obligatory role of beta1-adrenoceptors for putative beta4-adrenoceptor pharmacology. Naunyn-Schmiedeberg's Arch Pharmacol 363:87-93.
15. Kaumann AJ and Molenaar P (1997) Modulation of human cardiac function through 4 beta-adrenoceptor populations. Naunyn-Schmiedeberg's Arch Pharmacol 355: 667-681.
16. Kaumann AJ, Preitner F, Sarsero D, Molenaar P, Revelli JP, and Giacobino JP (1998) (-)-CGP 12177 causes cardiostimulation and binds to cardiac putative beta 4-adrenoceptors in both wild-type and beta 3-adrenoceptor knockout mice. Mol Pharmacol 53: 670-675.
17. Kenakin TP, Bond RA, and Bonner TI (1992) Definition of pharmacological receptors. Pharmacol Rev 44:351-362.
18. Kenakin T, Morgan P, and Lutz M (1995) On the importance of the antagonist assumption to how receptors express themselves. Biochem Pharmacol 50:17-26.
19. Kompa AR and Summers RJ (1999) Desensitization and resensitization of beta 1- and putative beta 4-adrenoceptor mediated responses occur in parallel in a rat model of cardiac failure. Br J Pharmacol 128:1399-1406.
20. Konkar AA, Zhai Y, and Granneman JG (2000a) Beta1-adrenergic receptors mediate beta3-adrenergic-independent effects of CGP 12177 in brown adipose tissue. Mol Pharmacol 57:252-258.
21. 1-adrenergic receptors. J Pharmacol Exp Ther 294:923-932.
22. Kozlowska H, Szymska U, Schlicker E, and Malinowska B (2003) Atypical beta-adrenoceptors, different from beta 3-adrenoceptors and probably from the low-affinity state of beta 1-adrenoceptors, relax the rat isolated mesenteric artery. Br J Pharmacol 140:3-12.
23. 1- adrenoceptor in ferret ventricular myocardium. Br J Pharmacol 135:451-461.
24. Mallem MY, Toumaniantz G, Serpillon S, Gautier F, Gogny M, Desfontis JC, and Gauthier C (2004) Impairment of the low-affinity state beta1-adrenoceptor- induced relaxation in spontaneously hypertensive rats. Br J Pharmacol 143:599-605.
25. 2-adrenoceptor. Br J Pharmacol 125:717-726.
26. Molenaar P (2003) The 'state' of beta-adrenoceptors. Br J Pharmacol 140:1-2.
27. Pak MD and Fishman PH (1996) Anomalous behaviour of CGP 12177A on beta 1-adrenergic receptors. J Recept Signal Transduc Res 16:1-23.
28. Sawangkoon S, Miyamoto M, Nakayama T, and Hamlin RL (2000) Acute cardiovascular effects and pharmacokinetics of carvedilol in healthy dogs. Am J Vet Res 61:57-60.
29. Staehelin M, Simons P, Jaeggi K, and Wigger N (1983) CGP-12177. A hydrophilic β-adrenergic receptor radioligand reveals high affinity binding of agonist to intact cells. J Biol Chem 258:3496-3502.
30. Yuan N, Friedman J, Whaley BS, and Clark RB (1994) cAMP-dependent protein kinase and protein kinase C consensus site mutations of the β-adrenergic receptor. Effect on desensitizaton and stimulation of adenylyl cyclase. J Biol Chem 269: 23032-23038.